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Conclusion:	  
Ø  The	  use	  of	  the	  Bakri	  balloon,	  as	  the	  sole	  second	  line	  approach	  in	  the	  
management	   of	   postpartum	   haemorrhage,	   when	   first	   line	  
uterotonics	  have	  failed,	  does	  not	  appear	  to	  be	  associated	  with	  any	  
adverse	  effects	  on	  subsequent	  ferLlity,	  pregnancy	  and	  deliveries.	  
Ø More	   data	  with	   respect	   to	   subsequent	   pregnancies	   and	  menstrual	  
funcLon	  are	  necessary	   to	  establish	   the	   long-­‐term	  safety	  of	  balloon	  
tamponade	  technology	  in	  the	  management	  of	  PPH	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Introduc9on:	  
Evidence-­‐based	  data	  depicts	  that	  various	  pharmacological	  agents	  should	  be	  used	  
as	  a	  first	  line	  approach	  in	  the	  management	  of	  PPH	  aber	  rubbing	  up	  the	  uterus.	  If	  
these	  first	  line	  uterotonics	  (FLU)	  are	  unsuccessful,	  various	  second-­‐line	  approaches	  
(SLA)	  have	  been	  advocated	  including	  balloon	  tamponade	  technology.1	  	  
	  
Although	  many	  factors	  are	  considered	  when	  deciding	  which	  SLA	  is/are	  to	  be	  used,	  
the	   parity	   of	   the	   mother	   and	   her	   potenLal	   future	   ferLlity	   is	   an	   important	  
consideraLon.	   Consequently,	   hysterectomy	   is	   not	   always	   the	   first	   choice	   in	  
women	  of	   low	  parity.	  The	  belief	   is	   that	  by	  sparing	   the	  uterus,	  a	  paLent’s	   future	  
ferLlity	  is	  preserved	  (Table	  1).2	  
Despite	  the	   increasing	  number	  of	  publicaLons	  demonstraLng	  an	  effecLve	  use	  of	  
the	   uterine-­‐specific	   Bakri	   balloon	   (Cook	   Medical,	   Bloomington,	   USA),	   few	  
publicaLons	  have	  commented	  on	  subsequent	  pregnancies	  in	  such	  cases	  (Fig.	  1).	  	  
	  
Four	  cases	  are	  described	  in	  which	  a	  subsequent	  pregnancy	  occurred	  following	  the	  
use	  of	  a	  Bakri	  balloon	   that	  was	  solely	  used	  as	  a	  SLA	   in	   the	  management	  of	  PPH	  
when	  FLU	   failed.	  These	  examples	  were	   idenLfied	   from	  a	  personal	   case	  series	  of	  




A	  26	  yr	  old	  Jehovah’s	  Witness,	  with	  an	  uncomplicated	  first	  pregnancy,	  presented	  
in	   established	   labour	   at	   39	   weeks	   gestaLon.	   Following	   the	   vaginal	   birth	   of	   her	  
baby	   and	   placenta,	   profuse	   PPH	   occurred.	   Despite	   the	   use	   of	   10iu	   im	   oxytocin,	  
250ug	   ergometriene	   and	   40iu	   oxytocin	   infusion,	   bleeding	   persisted.	   A	  
combinaLon	   of	   an	   atonic	   uterus,	   cervical/vaginal	   trauma	   was	   idenLfied	   in	   the	  
operaLng	  theatre.	  A	  Bakri	  balloon	  was	  insufflated	  with	  450mls	  N-­‐Saline	  (in	  order	  
to	  achieve	  a	  posiLve	  tamponade	  test),	  together	  with	  the	  appropriate	  repair	  of	  the	  
genital	   tract	   trauma.	   EsLmated	   blood	   loss	   (EBL)	   was	   2.5l.	   The	   balloon	   eas	  
removed	   within	   24hrs	   with	   conLnual	   oxytocin	   infusion.The	   paLent	   was	  
discharged	  on	  day	  4	  and	  was	  seen	  at	  6	  weeks	  with	  an	  ultrasound	  scan	  (USS)	  that	  
was	   reported	   as	   “normal”.	   In	   addiLon,	   normal	   menses	   returned	   following	  
cessaLon	  of	  breast	  feeding.	  
	  
Subsequent	  pregnancy:	  
Eighteen	  months	  later,	  this	  woman	  presented	  at	  6	  weeks	  gestaLon.	  At	  39+1	  weeks	  
gestaLon,	  she	  had	  a	  social	  inducLon	  of	  labour	  using	  ARM,	  due	  to	  living	  at	  a	  distant	  
locaLon	  with	  respect	  to	  the	  main	  hospital.	  Four	  hours	  later,	  she	  birthed	  her	  baby	  
with	  a	  first	  degree	  perineal	  tear	  that	  eventually	  was	  sutured.	  AcLve	  management	  
of	   the	  third	  stage	  together	  with	  a	  40	   IU	  syntocinon	   infusion	  was	  commenced	  as	  
previously	  planned	  throughout	  her	  pregnancy.	  	  
	  
Despite	   this,	   a	   subsequent	   trickle	   of	   blood	   ensued	   that	   was	   managed	   with	   PR	  
misoprostol	   (800mcg)	   and	   IM	   (250mcg)	   ergometriene.	   A	   total	   esLmated	   blood	  
loss	   of	   1000mls	   was	   recorded.	   The	   paLent	   was	   discharged	   on	   the	   second	   day	  
following	  delivery,	  aber	  breast-­‐feeding	  was	  established.	  
CASE	  2:	  
Index	  pregnancy	  
A	   28yr	   old	   nulliparous	   woman	   with	   pregnancy	   induced	   hypertension	   requiring	  
pharmacological	   treatment	   (labetolol	   100mg,	   twice	   daily)	   was	   admiked	   in	   early	  
labour	   at	   37+5	   weeks	   gestaLon.	   Following	   the	   birth	   of	   her	   baby,	   a	   retained	  
placenta	  was	  manually	  removed	  piecemeal.	  	  
	  
A	   PPH	   secondary	   to	   an	   atonic	   uterus	   ensued.	   Despite	   the	   use	   of	   first	   line	  
uterotonics,	  a	  Bakri	  balloon,	  insufflated	  to	  400mls	  was	  required	  in	  order	  to	  achieve	  
a	  posiLve	  tamponade	  test.	  The	  final	  EBL	  was	  3500mls.	  A	  syntocinon	  infusion	  (40iu	  
oxytocin)	   was	   conLnued	   unLl	   the	   Bakri	   balloon	   was	   removed,	   within	   24	   hrs	   of	  
placement.	  Two	  units	  of	  blood	  were	  required.	  The	  paLent	  was	  discharged	  on	  Day	  
4	  and	  was	  seen	  in	  an	  outpaLent	  selng	  at	  6	  weeks,	  whilst	  sLll	  breast-­‐feeding.	  An	  
USS	  at	  this	  stage	  revealed	  a	  uterus	  which	  was	  “unremarkable	  in	  appearance”.	  The	  
histopathology	  of	   the	  placenta	  was	   reported	  as	  normal	  and	  without	  evidence	  of	  
placenta	   accreta.	   Regular	   normal	   menses	   commenced	   when	   breast-­‐feeding	  
ceased	  at	  10	  weeks.	  
	  
Subsequent	  pregnancy	  
Twenty-­‐three	  months	  later	  this	  woman	  presented	  in	  her	  second	  pregnancy	  at	  14	  
weeks	   pregnant	   with	   a	   booking	   BP	   of	   110/66.	   She	   was	   no	   longer	   on	   any	   anL-­‐
hypertensive	  medicaLon.	  A	  19-­‐week	  anomaly	   scan	   indicated	   the	  presence	  of	   an	  
anterior	   placenta	   with	   a	   posterior	   succenturiate	   lobe.	   This	   was	   not	   low	   lying.	  
AcLve	  management	  of	  the	  third	  stage	  together	  with	  a	  prophylacLc	  40iu	  oxytocin	  
infusion	  was	  recommended.	  The	  remainder	  of	  the	  pregnancy	  was	  uncomplicated.	  
	  
Spontaneous	   labour	   ensued	   at	   38+5	   weeks	   gestaLon.	   This	   was	   followed	   by	   a	  
vaginal	   delivery	  2hrs	   following	   the	   spontaneous	   rupture	  of	  membranes,	  without	  
the	  need	  of	  an	  oxytocin	  augmentaLon.	  The	  placenta	  was	  delivered	  and	  considered	  
complete	  with	  the	  idenLficaLon	  of	  the	  succenturiate	  lobe.	  AcLve	  management	  of	  
the	   third	   stage,	   together	   with	   a	   prophylacLc	   40iu	   oxytocin	   infusion,	   was	  
performed	  and	  a	  total	  esLmated	  blood	  loss	  of	  300mls	  was	  recorded.	  The	  paLent	  
was	  discharged	  on	  the	  third	  day	  following	  delivery.	  This	  was	  aber	  breast-­‐feeding	  
was	  established.	   	  The	  paLent	  was	  seen	  at	  7	  weeks	  and	  although	  she	  conLnued	  to	  
breast-­‐feed,	  her	  periods	  returned	  and	  were	  described	  as	  normal.	  
CASE	  3:	  
Index	  pregnancy	  
A	   28yr	   old	  mulLparous	   woman	   in	   her	   4th	   ongoing	   pregnancy	   presented	   at	   37+2	  
weeks	  with	  spontaneous	  rupture	  of	  membranes	  and	  draining	  clear	  liquor.	  She	  had	  
experienced	  three	  previous	  vaginal	  deliveries	  and	  the	  last	  one	  was	  complicated	  by	  
a	  PPH	  following	  the	  manual	  removal	  of	  the	  placenta.	  
She	  birthed	  her	  baby	  24hrs	  later	  and	  she	  was	  administered	  10iu	  oxytocin,	  IM.	  The	  
placenta	  was	  noted	  to	  be	  adherent	  and	  a	  40iu	  oxytocin	  infusion	  was	  commenced.	  
Despite	   this	   and	   repeated	   intermikent	   akempts	   to	   remove	   the	   placenta	   by	  
controlled	   cord	   tracLon,	   the	   placenta	   remained	   adherent.	   The	   woman	   was	  
transferred	   to	   the	   operaLng	   theatre	   for	   manual	   removal	   of	   the	   placenta.	  
Following	   this,	   bleeding	   ensued	   and	   despite	   the	   addiLonal	   use	   of	   ergometriene	  
(250mcg)	   and	  misoprostol	   (800ug),	   the	   uterus	   remained	   atonic.	   A	   decision	   was	  
made	  to	  use	  a	  Bakri	  balloon.	  
	  
A	  posiLve	  tamponade	  test	  was	  achieved	  at	  450mls	  N-­‐Saline.	  A	  final	  EBL	  of	  1000mls	  
was	  recorded.	  Three	  units	  of	  blood	  were	  transufused.	  The	  woman	  was	  discharged	  
on	  day	  3	   following	  the	  birth	  of	  her	  baby	  with	   the	  view	  of	  akending	  her	  GP	  with	  
respect	   to	   tubal	   ligaLon.	  She	  ceased	  breast-­‐feeding	  at	  7	  weeks	  and	  experienced	  
her	  first	  menses	  at	  8	  weeks	  and	  this	  was	  also	  described	  as	  normal.	  	  
	  
Subsequent	  pregnancy	  
15	   months	   later,	   she	   presented	   with	   a	   subsequent	   pregnancy	   at	   10	   weeks	  
gestaLon.	  She	  did	  not	  manage	  to	  akain	  tubal	  sterilizaLon.	  A	  similar	  management	  
plan	  involving	  controlled	  cord	  tracLon	  and	  the	  use	  of	  prophylacLc	  40iu	  syntocinon	  
infusion	  was	  recommended.	  
	  
Her	  antenatal	  care	  was	  unremarkable,	  but	  she	  relocated	  to	  a	  different	  State	  and	  
presented	   at	   37	   weeks	   in	   labour.	   Following	   the	   birth	   of	   her	   baby	   she	   again	  
required	   a	  manual	   removal	   of	   the	   placenta	   in	   theatre.	   There	  was	   an	   esLmated	  
blood	  loss	  of	  400mls.	  Despite	  this	  amount	  of	  bleeding,	  a	  Bakri	  balloon	  insufflated	  
to	   500mls	   was	   inserted	   following	   the	   manual	   removal	   “as	   a	   precauLonary	  
measure”.	  This	  was	  removed	  within	  24hrs.	  	  
She	  conLnued	  to	  breast-­‐feed	  for	  only	  6	  weeks	  postpartum	  and	  then,	  experienced	  
her	  1st	  period	  at	  8	  weeks.	  Her	  USS	  at	  this	  Lme	  was	  described	  as	  unremarkable.	  
CASE	  4:	  
Index	  pregnancy	  
A	  25yr	  old	  nulliparous	  woman	  presented	  at	  37+2	  weeks	  with	  spontaneous	  rupture	  
of	   membranes	   and	   draining	   clear	   liquor	   in	   an	   otherwise	   uncomplicated	  
pregnancy.	  
She	  birthed	  her	  baby	  24hrs	  later	  and	  she	  was	  administered	  10iu	  oxytocin,	  IM.	  The	  
placenta	  was	  delivered	  and	  a	  PPH	  ensued,	  secondary	  to	  an	  atonic	  uterus.	  A	  40iu	  
oxytocin	  infusion	  was	  commenced.	  Despite	  the	  use	  of	  ergometriene	  (250mcg)	  and	  
misoprostol	   (800ug),	   the	  uterus	   remained	  atonic.	  A	  decision	  was	  made	   to	  use	  a	  
Bakri	  balloon.	  
The	   woman	   was	   transferred	   to	   the	   operaLng	   theatre	   and	   a	   Bakri	   balloon	   was	  
inserted,	  450mls	  was	  required	  to	  obtain	  a	  posiLve	  tamponade	  test.	  A	  final	  EBL	  of	  
2000mls	   was	   recorded.	   Three	   units	   of	   blood	  were	   transfused.	   The	   woman	  was	  
discharged	  on	  day	  3	   following	  the	  birth	  of	  her	  baby.	  She	  planned	  to	  breast	   feed	  
and	   use	   the	   Progesterone	   only	   pill	   as	   a	  method	   of	   contracepLon.	   	   She	   ceased	  
breast-­‐feeding	   at	   5	  months	   and	   experienced	   her	   first	  menses	   at	   this	   Lme.	   The	  
periods	  were	  described	  as	  normal.	  An	  USS	  at	  this	  Lme	  was	  reported	  as	  normal.	  
	  
Subsequent	  pregnancy	  
29	   months	   later,	   she	   presented	   with	   a	   subsequent	   pregnancy	   at	   13	   weeks	  
gestaLon.	   In	   addiLon	   to	   her	   rouLne	   antenatal	   care	   a	   similar	  management	   plan	  
involving	  controlled	  cord	  tracLon	  and	  the	  use	  of	  prophylacLc	  40iu	  syntocinon	  was	  
recommended,	  as	  with	  the	  other	  cases.	  
Antenatal	  care	  was	  unremarkable,	  and	  she	  presented	  in	  early	  labour	  at	  40	  weeks	  
and	   2	   days.	   She	   progressed	   to	   full	   dilataLon	   and	   following	   an	  ARM	  birthed	   her	  
baby.	   The	   placenta	   was	   subsequently	   delivered	   following	   the	   administraLon	   of	  
10iu	   oxytocin	   IM.	   She	   experienced	   a	   second	   degree	   tear	   that	   required	   suturing	  





39 Cases Worldwide (Bakri balloon)
Original description
Bakri et al., 2001 (4*2 Cases)
Bakri / B-Lynch Sandwich
Nelson and O’Brien, 2007 (5*5 Cases)
2 principle publications (30 Cases)
Retrospective
Dabelea et al., 2007 (15 Cases) - UK
Vitthala et al., 2009 (15 Cases) - USA






61 Cases Worldwide (Bakri balloon)
Original description
Bakri et al., 2001 (4*2 Cases)
Bakri / B-Lynch Sandwich
Nelson and O’Brien, 2007 (5*5 Cases)
Diemert et al., 2012 (20*6 Cases)
Intra-uterine pressures
Georgiou, 2010 (2 Cases)
2 principle publications (30 Cases)
Retrospective
Dabelea et al., 2007 (15 Cases) - UK
Vitthala et al., 2009 (15 Cases) - USA
No published data (Others)
Uterine Specific Balloons
Dec. 2009 Jan. 2012





111 Cases Worldwide (Bakri balloon)
Original description
Bakri et al., 2001 (4*2 Cases)
Bakri / B-Lynch Sandwich
Nelson and O’Brien, 2007 (5*5 Cases)
Diemert et al., 2012 (20*6 Cases)
Intra-uterine pressures
Georgiou, 2010 (2 Cases)
3 principle publications (90 Cases)
Retrospective
Dabelea et al., 2007 (15 Cases) - UK
Vitthala et al., 2009 (15 Cases) - USA
 Gronvall et al, (50 Cases) - Finland






150 Cases Worldwide (Bakri balloon)
Original description
Bakri et al., 2001 (4*2 Cases)
Bakri / B-Lynch Sandwich
Nelson and O’Brien, 2007 (5*5 Cases)
Diemert et al., 2012 (20*6 Cases)
Intra-uterine pressures
Georgiou, 2010 (2 Cases)
5 principle publications (149 Cases)
Retrospective
Dabelea et al., 2007 (15 Cases) - UK
Vitthala et al., 2009 (15 Cases) - USA
Gronvall et al, 2012 (50 Cases) - Finland
Patacchiola et al., 2012 (16 Cases) - Italy
Laas et al., 2012 (43 Cases) - France
No published data (Others)
Uterine Specific Balloons
Dec. 2009 Jan. 2012
Dec. 2012 May. 2013
Figure	  1:	  The	  steady	  increase	  in	  publicaLons	  involving	  the	  Bakri	  balloon	  over	  the	  last	  3.5yrs	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artery	  liga9on	   11	   98	   63	   16-­‐40	   G:1-­‐8	  	  P:0-­‐6	   Not	  specified	  
2	  cycles	  to	  52	  
days	  
"Light",	  "Normal",	  
"Regular"	   36	   10	  weeks	  -­‐	  7yrs	   41	   5	   6	   2	   0	   28	  
Uterine	  artery	  
liga9on	   9	   373	   229	   19-­‐45	   G:2-­‐4	  	  P:1-­‐6	   12-­‐99	   40-­‐60	  days	  
"Ammenorhea",	  
"Normal	  in	  rhythum	  
duraLon	  and	  amount",	  
"Unaltered"	  
59	   1	  	  month	  -­‐	  3.6yrs	   56	   2	   0	   1	   1	   52	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